• Study reports abnormally high VTE and high bleed risk in critically ill COVID-19 patients and calls for more effective prevention strategies.
  • Clinicians at NHS hospitals are supporting the care of COVID-19 patients with the use of geko™ devices to reduce the risk of blood clots in the most at risk patients.
Learn more Contact us

Accelerate – geko™ device – Product Evaluation and Welsh Supply Chain Logistics – An Innovation Case Study


April 2021

An Innovation Case Study (English)

An Innovation Case Study (Welsh)


PARTNERS: Gwalia Healthcare, Sky Medical Technology,
Aneurin Bevan University Health Board and Cardiff University

PROJECT AIM: To undertake a clinical product evaluation of the geko™ device in patients with symptoms of COVID-19, and, to enhance the device manufacturer’s capabilities, resilience and sustainability within Wales